Prosurgics
Investors Count
8Prosurgics Funding, Prosurgics Valuation & Prosurgics Revenue
1 Fundings
Prosurgics's latest funding round was a Other Investors for on .
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
Other Investors |
Date | |
---|---|
Round | Other Investors |
Amount | |
Investors | |
Valuation | |
Revenue | |
Sources |
Prosurgics Investors
8 Investors
Prosurgics has 8 investors. Chord Capital invested in Prosurgics's Other Investors funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
1 Other Investors | Venture Capital | United Kingdom | ||||
Corporation | United Kingdom | |||||
Asset/Investment Management | United Kingdom | |||||
First funding | |||||
---|---|---|---|---|---|
Last Funding | |||||
Investor | |||||
Rounds | 1 Other Investors | ||||
Board Seats | |||||
Type | Venture Capital | Corporation | Asset/Investment Management | ||
Location | United Kingdom | United Kingdom | United Kingdom |
Prosurgics Acquisitions
1 Acquisition
Prosurgics acquired 1 company. Their latest acquisition was Schaerer Mayfield Technologies on September 13, 2007.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/13/2007 | Asset Sale | 1 |
Date | 9/13/2007 |
---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Asset Sale |
Sources | 1 |
You May Also Like
CardioVention develops cardiopulmonary bypass systems

Biointraface is developing a technology to thwart infection relating to medical-device use.

Neuros Medical focuses on the development of proprietary therapies for unmet needs to patients worldwide. The company’s patented platform technology, Electrical Nerve Block, focuses on the treatment of chronic pain in a variety of applications including post-amputation pain, chronic post surgical pain, and chronic migraine.
The GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Its unique portfolio of medical, professional & consumer audio solutions – and the deep research & development expertise behind this range of products gives our brands unprecedented advantages in the med-tech, hearables and intelligent audio field.
Ark Sciences LLC develops pharmaceutical products for animals and their pharmaceutical products are specifically engineered to provide the least invasive, non-surgical sterilization processes possible. Rather than castrating dogs, which can be painful and lead to possibly harmful side-effects, with Ark Sciences' patent protected products, veterinarians and animal welfare specialists have a safe, reliable and cost-effective sterilization treatment.
CIVCO Medical Solutions is a manufacturer of ultrasound guidance devices and infection control products. CIVCO Medical Solutions is committed to positively impacting patient care by constantly innovating life enhancing medical solutions.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.